Merck to reveal new major installment to support health research with a translational component in Quebec

These multi-million dollar grants will be used to enhance the academic research environment at four Quebec Universities

QUEBEC CITY, Oct. 2, 2013 /CNW Telbec/ - Members of the media are invited to a press conference during which new multi-million dollar grants to support health research with a translational component will be announced as the next installment of the $100-million commitment of Merck to fund research innovation in Quebec.

The announcement will be made during the BioContact Quebec 2013 biopharmaceutical partnership symposium, on October 3^rd, 2013.

Reminder:

What:	Press conference of Merck Canada at BioContact Quebec 2013
Who:	Mr. Pierre Duchesne, Minister of Higher Education, Research, Science and Technology Dr. Thomas R. Cannell, President and Managing Director, Merck Canada Inc. Mr. Denis Brière, President, Université Laval Pr. Daniel Bourbonnais, Associate Dean-Research and Scientific Innovation, Université de Montréal Pr. Jean-Pierre Perreault, PhD, Vice-Dean of Research and Graduate Studies, Faculté de médecine et des sciences de la santé, Université de Sherbrooke Philippe Gros, PhD, Vice-Dean, Life Sciences, Faculty of Medicine, McGill University
When:	Thursday, October 3^rd, 2013 at 1:30 p.m.
	1:30 p.m.	Press conference begins
	1:55 p.m.	One-on-one interviews and photo opportunity
Where:	Hotel Chateau Laurier Quebec - Espace Foyer des Plaines 1220, Place George-V West Quebec City, Quebec G1R 5B8

 

 

SOURCE: Merck

For further information:

Sylvie Patry
[e-mail]
Office : 418-648-1233 ex: 232
Mobile : [phone]

Stephanie Lyttle
[e-mail]
Office: 514-843-2365
Mobile: [phone]

Roch Landriault
[e-mail]
Office: 514-843-2345
Mobile: [phone]